Knowledge Library
Meeting on the Mesa: The evolution of cell and gene therapy in China
Senior executives active in the region will share their experience and outlook on the cell and gene therapy industry in China, with advice for those considering expansion or are new to the market. Click the Image Below to View the Webcast Now on YouTube:
Navigating regulatory expectations for extractables and leachables of combination products
The expectations for extractables and leachables of medical devices (delivery systems) are different than those of typical pharmaceutical applications such as container closure systems or single use systems. Learn about how the FDA reviews combination products and learn about testing expectations. Put these expectations to practice with a case study review complete including common pitfalls …Read More >
Roundtable discussion: Cell and gene therapies — Keep the work in-house, or use a third party?
During BIO 2019, BioProcess International hosted a roundtable discussion on “Cell and Gene Therapies – Keep the work in-house or use a third party” at BPI Theater. It was moderated by BioProcess Insider editor Dan Stanton with industry leaders that included Felix Hsu, Senior Vice President and Global Head of WuXi Advanced Therapies, Celonic Group, …Read More >
Contract Pharma interview with SVP and global head of advanced therapies talks about cell and gene therapy market trends
WuXi AppTec’s Felix Hsu on ‘Make vs Buy’ Decisions At BIO 2019, Contract Pharma had a chance to talk with WuXi AppTec’s Felix Hsu, SVP and Global Head of Advanced Therapies, about “Make vs Buy” decisions, as well as cell and gene therapy market trends.